Los Angeles Capital Management LLC Fulgent Genetics, Inc. Transaction History

Los Angeles Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$37.92 - $63.74 $357,623 - $601,131	-9,431 Reduced 48.08%	10,183 $388,000
Q2 2022 Aug 05, 2022	BUY	$47.98 - $62.75 $402,456 - $526,347	8,388 Added 74.72%	19,614 $1.07 Million
Q1 2022 May 06, 2022	BUY	$49.85 - $96.11 $140,925 - $271,702	2,827 Added 33.66%	11,226 $701,000
Q4 2021 Feb 03, 2022	BUY	$77.3 - $105.0 $124,221 - $168,735	1,607 Added 23.66%	8,399 $845,000
Q2 2021 Aug 05, 2021	SELL	$66.8 - $100.45 $118,904 - $178,801	-1,780 Reduced 20.77%	6,792 $626,000
Q1 2021 May 05, 2021	SELL	$59.3 - $183.85 $932,611 - $2.89 Million	-15,727 Reduced 64.72%	8,572 $828,000
Q4 2020 Feb 04, 2021	BUY	$31.01 - $52.1 $753,511 - $1.27 Million	24,299 New	24,299 $1.27 Million

198

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $504M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.